利妥昔单抗在类固醇难治性慢性移植物抗宿主病中的安全性和疗效。 - Suppr

Safety and efficacy of rituximab in steroid-refractory chronic GVHD.

作者信息

Clavert A, Chevallier P, Guillaume T, Delaunay J, Le Gouill S, Mahe B, Dubruille V, Gastinne T, Blin N, Moreau P, Mohty M

出版信息

Bone Marrow Transplant. 2013 May;48(5):734-6. doi: 10.1038/bmt.2012.203. Epub 2012 Oct 22.

DOI:10.1038/bmt.2012.203

PMID:23085828

Abstract

摘要

相似文献

Safety and efficacy of rituximab in steroid-refractory chronic GVHD.

Bone Marrow Transplant. 2013 May;48(5):734-6. doi: 10.1038/bmt.2012.203. Epub 2012 Oct 22.

Lack of efficacy of rituximab in refractory sclerodermatous chronic GVHD.

Bone Marrow Transplant. 2012 May;47(5):737-8. doi: 10.1038/bmt.2011.150. Epub 2011 Jul 25.

Repeated course of rituximab for treatment of nephrotic syndrome in patients with chronic GVHD.

Bone Marrow Transplant. 2010 Dec;45(12):1758-9. doi: 10.1038/bmt.2010.58. Epub 2010 Apr 12.

Rituximab as a treatment for factor VIII inhibitor in a patient with chronic GVHD.

Bone Marrow Transplant. 2014 Apr;49(4):588. doi: 10.1038/bmt.2013.229. Epub 2014 Jan 20.

Prior rituximab administration is associated with reduced rate of acute GVHD after in vivo T-cell depleted transplantation in lymphoma patients.

Exp Hematol. 2011 Sep;39(9):892-6. doi: 10.1016/j.exphem.2011.06.006. Epub 2011 Jun 16.

Rituximab is effective for extensive steroid-refractory chronic graft-vs.-host-disease.

Leuk Lymphoma. 2007 Mar;48(3):623-4. doi: 10.1080/10428190601094362.

Sustained complete remission with single agent rituximab in relapsed follicular lymphoma as transformed disease after unrelated reduced intensity conditioning allogeneic stem cell transplantation.

Ann Hematol. 2011 Feb;90(2):227-9. doi: 10.1007/s00277-010-0987-0. Epub 2010 May 27.

Rituximab in critically ill patients.

Minerva Anestesiol. 2013 Feb;79(2):185-93. Epub 2012 Nov 8.

Clinical utility of rituximab in chronic graft-versus-host disease.

Ann Pharmacother. 2009 Feb;43(2):316-21. doi: 10.1345/aph.1L386. Epub 2009 Feb 3.

Rituximab is effective for steroid-refractory sclerodermatous chronic graft-versus-host disease.

Leukemia. 2006 Jan;20(1):172-3. doi: 10.1038/sj.leu.2403996.

引用本文的文献

Ruxolitinib-ECP combination treatment for refractory severe chronic graft-versus-host disease.

Bone Marrow Transplant. 2021 Apr;56(4):909-916. doi: 10.1038/s41409-020-01122-8. Epub 2020 Nov 17.

How I treat refractory chronic graft-versus-host disease.

Blood. 2019 Mar 14;133(11):1191-1200. doi: 10.1182/blood-2018-04-785899. Epub 2019 Jan 23.

Comprehensive B Cell Phenotyping Profile for Chronic Graft-versus-Host Disease Diagnosis.

Biol Blood Marrow Transplant. 2019 Mar;25(3):451-458. doi: 10.1016/j.bbmt.2018.11.007. Epub 2018 Nov 14.

Steroid Refractory Chronic Graft-Versus-Host Disease: Cost-Effectiveness Analysis.

Biol Blood Marrow Transplant. 2018 Sep;24(9):1920-1927. doi: 10.1016/j.bbmt.2018.03.008. Epub 2018 Mar 14.

The Role of B Cell Targeting in Chronic Graft-Versus-Host Disease.

Biomedicines. 2017 Oct 17;5(4):61. doi: 10.3390/biomedicines5040061.

Effect of Rituximab on Pulmonary Function in Bronchiolitis Obliterans Syndrome due to Graft-Versus-Host-Disease.

Lung. 2017 Dec;195(6):781-788. doi: 10.1007/s00408-017-0051-0. Epub 2017 Sep 11.

Rituximab-based treatments followed by adoptive cellular immunotherapy for biopsy-proven EBV-associated post-transplant lymphoproliferative disease in recipients of allogeneic hematopoietic stem cell transplantation.

Oncoimmunology. 2016 Mar 10;5(5):e1139274. doi: 10.1080/2162402X.2016.1139274. eCollection 2016 May.

A Randomized Phase II Crossover Study of Imatinib or Rituximab for Cutaneous Sclerosis after Hematopoietic Cell Transplantation.

Clin Cancer Res. 2016 Jan 15;22(2):319-27. doi: 10.1158/1078-0432.CCR-15-1443. Epub 2015 Sep 16.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

Safety and efficacy of rituximab in steroid-refractory chronic GVHD.

作者信息

出版信息

相似文献

引用本文的文献

文献AI研究员

用中文搜PubMed

文档翻译

Suppr 超能文献

相似文献

引用本文的文献